BG97199A - Антикоагулантен препарат - Google Patents

Антикоагулантен препарат

Info

Publication number
BG97199A
BG97199A BG097199A BG9719992A BG97199A BG 97199 A BG97199 A BG 97199A BG 097199 A BG097199 A BG 097199A BG 9719992 A BG9719992 A BG 9719992A BG 97199 A BG97199 A BG 97199A
Authority
BG
Bulgaria
Prior art keywords
anticoagulant preparation
preparation
anticoagulant
eri
extrinsic
Prior art date
Application number
BG097199A
Other languages
English (en)
Other versions
BG61181B1 (bg
Inventor
Ole Nordfang
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of BG97199A publication Critical patent/BG97199A/bg
Publication of BG61181B1 publication Critical patent/BG61181B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Materials For Medical Uses (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Abstract

1. Фармацевтичен препарат за профилактика или лечение на нарушения в кръвосъсирването или рак, характеризиращ се с това, че съдържа един външен инхибитор /ерi/ протеин и хепарин или друг мукополизахарид заедно с приемлив разтворител или вехикул. 15 претенции, 3 фигури
BG97199A 1990-06-19 1992-12-18 Антикоагулантен препарат BG61181B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat
PCT/DK1991/000145 WO1991019514A1 (en) 1990-06-19 1991-05-30 An anticoagulant preparation

Publications (2)

Publication Number Publication Date
BG97199A true BG97199A (bg) 1993-12-24
BG61181B1 BG61181B1 (bg) 1997-02-28

Family

ID=8105367

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97199A BG61181B1 (bg) 1990-06-19 1992-12-18 Антикоагулантен препарат

Country Status (11)

Country Link
EP (1) EP0535129B1 (bg)
JP (1) JP3362038B2 (bg)
AT (1) ATE119781T1 (bg)
AU (1) AU645581B2 (bg)
BG (1) BG61181B1 (bg)
CA (1) CA2085101A1 (bg)
DE (1) DE69108242T2 (bg)
DK (2) DK148890D0 (bg)
ES (1) ES2069894T3 (bg)
HU (1) HU221323B1 (bg)
WO (1) WO1991019514A1 (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
AU4408493A (en) * 1992-06-11 1994-01-04 Washington University Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders
ZA941414B (en) * 1993-03-02 1994-09-28 Novo Nordisk A G Non-glycosylated TFPI analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
EP1446140A4 (en) 2001-10-15 2007-03-07 Novartis Vaccines & Diagnostic TREATMENT OF HEAVY PNEUMONIA BY ADMINISTRATION OF TFPI (TISSUE FACTOR PATHWAY INHIBITOR)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3170001D1 (en) * 1980-09-30 1985-05-23 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
DK148890D0 (da) 1990-06-19
CA2085101A1 (en) 1991-12-20
HU221323B1 (en) 2002-09-28
DE69108242T2 (de) 1995-07-06
HUT63578A (en) 1993-09-28
EP0535129A1 (en) 1993-04-07
AU645581B2 (en) 1994-01-20
JP3362038B2 (ja) 2003-01-07
AU8060491A (en) 1992-01-07
BG61181B1 (bg) 1997-02-28
ES2069894T3 (es) 1995-05-16
HU9204036D0 (en) 1993-03-29
ATE119781T1 (de) 1995-04-15
JPH05507926A (ja) 1993-11-11
DK0535129T3 (da) 1995-08-07
DE69108242D1 (de) 1995-04-20
EP0535129B1 (en) 1995-03-15
WO1991019514A1 (en) 1991-12-26

Similar Documents

Publication Publication Date Title
DE69014552D1 (de) Zentrifugalblutpumpe.
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
DE69020558D1 (de) Blutpumpe.
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
KR890011606A (ko) 항응고제
DE69008638D1 (de) Transfusionspumpe.
DE68909691D1 (de) Multischichtkörper zur Abgabe von Duftstoffen.
DE69005347D1 (de) Absaugkanüle für chirurgische Zwecke, insbesondere für Fettabsaugung.
MX9603925A (es) Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
NO893637L (no) Fremgangsmaate for aa stabilisere blodkoagulasjonsfaktorer.
BG97199A (bg) Антикоагулантен препарат
AU2742892A (en) An anticoagulant substance obtained from urine
DK261490D0 (da) New pharmaceutical compound
ATE263187T1 (de) Neuartige heparin bindende peptide
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
DE68910100D1 (de) Mittel zur Bluttrennung.
EP0361490A3 (en) Sulfated oligosaccharides and derivatives thereof
ATE95818T1 (de) Protein-s-haeltige pharmazeutische praeparation.
DE3885798D1 (de) Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen.
BG60089B2 (bg) Състав за отстраняване или инактивиране на вредни съставки в кръвта у хора и животни
RU92016457A (ru) Антикоагулирующий препарат
DK453387D0 (da) Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
SE8900564D0 (sv) Novel medicinal use